Affirm Holdings, Inc. SEC Filings

Affirm Holdings, Inc. (AFRM) Form 4 shows insider transactions by Chief Accounting Officer Jiyane Siphelele. The filing discloses sales executed under a Rule 10b5-1 trading plan adopted December 8, 2024, and the settlement/vesting of restricted stock units (RSUs). On 08/29/2025 the reporting person sold 10,017 shares at $92 and 12,708 shares at $100, and on 09/01/2025 sold 4,545 shares at $88.46; these sales reduced holdings to 226,467 Class A shares. The filing also shows an acquisition/settlement of 11,545 shares and multiple RSU vesting events that increased beneficial ownership in specified amounts.

Affirm Holdings insider activity: Libor Michalek, a company director and the President, reported transactions on September 1, 2025. He received 23,612 shares of Class A common stock through vesting of restricted stock units and had 11,991 shares sold at $88.46 per share to satisfy tax withholding, reducing his direct beneficial ownership from 208,226 to 196,235 shares. He also reports indirect ownership of 868,114 Class A shares held by the Michalek 2007 Family Trust, where he and his spouse serve as trustees. The filing discloses two RSU grants with monthly and quarterly vesting schedules and no expiration.

Affirm Holdings insider activity: Michael Linford, the company's Chief Operating Officer, reported changes in his beneficial ownership on 09/01/2025. He had 25,031 shares of Class A common stock added under code M at a $0 price (reflecting settlement of restricted stock units) and sold 9,917 shares at $88.46 under code F. Following these transactions he beneficially owned 124,954 Class A shares. The filing also shows two RSU-related entries: 2,335 and 22,696 underlying Class A shares from separate RSU grants, with specified vesting schedules and no expiration. One sale was used to satisfy tax withholding related to RSU settlement.

Robert O'Hare, Chief Financial Officer of Affirm Holdings, Inc. (AFRM), reported multiple equity transactions on September 1-2, 2025. The Form 4 shows RSU vesting and option exercises that increased holdings and concurrent sales—including share withholding to satisfy taxes—executed under a Rule 10b5-1 trading plan adopted December 6, 2024. On September 1, 2025 the reporting person acquired 23,029 shares and had 23,029 shares beneficially owned following that transaction; subsequent activity on September 1-2 included tax-withheld shares (11,697) and a sequence of option exercises, RSU settlements and open-market sales at weighted-average prices in the $81.69–$85.50 range. The final non-derivative line shows a disposition that reduced the reported Class A common stock position to 0 shares for that line, while Table II lists multiple RSU and option holdings and resulting beneficial ownership counts for derivative awards.

Reporting person: Christa S. Quarles, a director of Affirm Holdings, Inc. (AFRM). The filing reports two open-market sales on 08/29/2025 totaling 15,000 Class A common shares — 10,000 shares sold at $92 and 5,000 shares sold at $95. After these transactions the reporting person beneficially owns 122,241 Class A shares directly. The filing indicates the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2024. The Form 4 is signed by an attorney-in-fact on behalf of the reporting person.

Form 144 notice reports a proposed sale of 31,423 shares of common stock through Morgan Stanley Smith Barney with an aggregate market value of $2,779,678.58 and approximately 284,917,717 shares outstanding. The shares to be sold were acquired on 09/02/2025 (20,091 shares via exercise of stock options) and 09/01/2025 (11,332 shares as restricted stock units), with cash used to pay for the option exercise. The filing also discloses three 10b5-1 sales by the same person during the past three months totaling 109,007 shares and gross proceeds of approximately $8,129,352.42. The filer affirms no undisclosed material adverse information and notes reliance on 10b5-1 sale instructions where applicable.

Max Levchin, Affirm Holdings CEO and director, reported transactions on 08/28/2025 executed under a Rule 10b5-1 plan adopted March 17, 2025. He acquired 499,223 Class A shares at an exercise price of $49 per share (transaction code M) related to vested performance-based options, and sold 499,223 Class A shares the same day at a weighted average price of $80.17 per share (transaction code S). After these transactions, Levchin reports 0 direct Class A shares held and 735,294 shares indirectly via the Levchin 2012 Irrevocable Trust; he also holds 11,818,381 options/derivatives and has earned 4,000,000 vested options under his Value Creation Award.

Affirm Holdings (AFRM) filed a Form 144 notifying a proposed sale of 15,000 common shares through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $1,199,850.00. The filer shows total outstanding common shares of 284,917,717, so the proposed sale represents a very small fraction of the outstanding stock. The securities were acquired as restricted stock units on 07/01/2022 (2,048 shares) and from previously exercised stock options on 11/17/2020 (12,952 shares). The filing also discloses a 10b5-1 sale of 754 shares on 07/01/2025 generating gross proceeds of $50,844.63. The filer attests there is no undisclosed material adverse information.

Affirm Holdings, Inc. (AFRM) Form 144 notice shows a proposed sale of 22,725 common shares (restricted stock units) by the holder, with an approximate aggregate market value of $1,817,772.75 and an intended sale date of 08/29/2025 on NASDAQ. The shares were acquired as RSUs on 01/01/2024 and the filing reports 284,917,717 shares outstanding for the issuer, providing context for the sale size relative to the company’s share count.

The filing also discloses prior 10b5-1 sales by the same person: 15,871 shares sold on 08/04/2025 generating $1,190,325.00 in gross proceeds. The filer attests they are not aware of any undisclosed material adverse information at the time of signing and notes reliance on Rule 10b5-1 for prior sales. The notice is a regulatory disclosure of an insider’s planned disposition and past 10b5-1 sales, without additional financial performance data.